Lili Su

P.R. China
Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Circulating NET Biomarkers as Predictors of Inflammatory Storm Escalation and Critical Illness in COVID-19.

Circulating NET Biomarkers as Predictors of Inflammatory Storm Escalation and Critical Illness in COVID-19.

Journal: Journal of microbiology and biotechnology

Published: September 02, 2025

Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention.

Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention.

Journal: Theranostics

Published: March 13, 2025

FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.

FXR shapes an immunosuppressive microenvironment in PD-L1lo/- non-small cell lung cancer by upregulating HVEM.

Journal: JCI insight

Published: January 17, 2025

SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer.

SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer.

Journal: Scientific reports

Published: January 03, 2025

Mechanisms of Bushenyiqi decoction in the treatment of asthma: an investigation based on network pharmacology with experimental validation.

Mechanisms of Bushenyiqi decoction in the treatment of asthma: an investigation based on network pharmacology with experimental validation.

Journal: Frontiers in pharmacology

Published: December 25, 2023

Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.

Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.

Journal: Cell death & disease

Published: January 22, 2023

Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.

Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.

Journal: Frontiers in immunology

Published: November 10, 2022

Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis.

Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis.

Journal: PloS one

Published: September 24, 2022

Disseminated Strongyloidiasis Misdiagnosed as Guillain-Barré Syndrome: The Value of High-Throughput Genetic Sequencing of Pathogenic Microorganisms in Parasitic Infections.

Disseminated Strongyloidiasis Misdiagnosed as Guillain-Barré Syndrome: The Value of High-Throughput Genetic Sequencing of Pathogenic Microorganisms in Parasitic Infections.

Journal: Infection and drug resistance

Published: July 27, 2022

Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review).

Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review).

Journal: Oncology reports

Published: January 30, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026